BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19364994)

  • 21. Positive tissue transglutaminase antibodies with negative endomysial antibodies: low rate of celiac disease.
    Weiss B; Bujanover Y; Avidan B; Fradkin A; Weintraub I; Shainberg B
    Isr Med Assoc J; 2004 Jan; 6(1):9-12. PubMed ID: 14740501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis.
    Sainsbury A; Sanders DS; Ford AC
    Clin Gastroenterol Hepatol; 2013 Apr; 11(4):359-65.e1. PubMed ID: 23246645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Prevalence of Anti-Zein Antibodies: A Comparative Study between Celiac Disease and Irritable Bowel Syndrome.
    Sánchez-Vargas LA; Hernández-Flores KG; Cabrera-Jorge FJ; Remes-Troche JM; Reyes-Huerta J; Vivanco-Cid H
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33671228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review.
    van der Windt DA; Jellema P; Mulder CJ; Kneepkens CM; van der Horst HE
    JAMA; 2010 May; 303(17):1738-46. PubMed ID: 20442390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis: yield of diagnostic tests for coeliac disease in dyspepsia.
    Ford AC; Ching E; Moayyedi P
    Aliment Pharmacol Ther; 2009 Jul; 30(1):28-36. PubMed ID: 19416130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coeliac disease in irritable bowel syndrome (Rome III) in Southeast Iran.
    Bakhshipour A; Nezam SK; Zakeri Z; Gharibi R; Bahari A; Kaykhaei MA
    Arab J Gastroenterol; 2012 Mar; 13(1):24-7. PubMed ID: 22560821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An excess of prior irritable bowel syndrome diagnoses or treatments in Celiac disease: evidence of diagnostic delay.
    Card TR; Siffledeen J; West J; Fleming KM
    Scand J Gastroenterol; 2013 Jul; 48(7):801-7. PubMed ID: 23697749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome.
    Korkut E; Bektas M; Oztas E; Kurt M; Cetinkaya H; Ozden A
    Eur J Intern Med; 2010 Oct; 21(5):389-92. PubMed ID: 20816591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The seroprevalence of celiac disease in patients with symptoms of irritable bowel syndrome: A cross-sectional study in the north of Iran.
    Joukar F; Yeganeh S; Shafaghi A; Mahjoub-Jalali MR; Hassanipour S; Santacroce L; Mavaddati S; Mansour-Ghanaei F
    Hum Antibodies; 2022; 30(2):97-103. PubMed ID: 35342083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice.
    Werkstetter KJ; Korponay-Szabó IR; Popp A; Villanacci V; Salemme M; Heilig G; Lillevang ST; Mearin ML; Ribes-Koninckx C; Thomas A; Troncone R; Filipiak B; Mäki M; Gyimesi J; Najafi M; Dolinšek J; Dydensborg Sander S; Auricchio R; Papadopoulou A; Vécsei A; Szitanyi P; Donat E; Nenna R; Alliet P; Penagini F; Garnier-Lengliné H; Castillejo G; Kurppa K; Shamir R; Hauer AC; Smets F; Corujeira S; van Winckel M; Buderus S; Chong S; Husby S; Koletzko S;
    Gastroenterology; 2017 Oct; 153(4):924-935. PubMed ID: 28624578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Performance of Nesfatin-1 in Distinguishing Irritable Bowel Syndrome Presenting Predominantly with Diarrhea from Celiac Disease.
    Karatay E; Gül-Utku Ö; Aksoy N
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celiac Disease in Patients Fulfilling the Rome III Criteria for Irritable Bowel Syndrome Attending Gastroenterology Department of A Tertiary Care Hospital in Bangladesh.
    Chowdhury MK; Chakraborty R; Gope S; Rahman MA; Miah AR; Raihan AS; Sarkar S; Paul BK; Ferdousi KR
    Mymensingh Med J; 2016 Jan; 25(1):102-8. PubMed ID: 26931258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis.
    Spiegel BM; DeRosa VP; Gralnek IM; Wang V; Dulai GS
    Gastroenterology; 2004 Jun; 126(7):1721-32. PubMed ID: 15188167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG.
    Pinto-Sanchez MI; Nardelli A; Borojevic R; De Palma G; Calo NC; McCarville J; Caminero A; Basra D; Mordhorst A; Ignatova E; Hansen S; Uhde M; Norman GL; Murray JA; Smecuol E; Armstrong D; Bai JC; Schuppan D; Collins SM; Alaedini A; Moayyedi P; Verdu EF; Bercik P
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2343-2352.e8. PubMed ID: 32827724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Irritable bowel syndrome, celiac disease and gluten].
    Mearin F; Montoro M
    Med Clin (Barc); 2014 Aug; 143(3):124-9. PubMed ID: 24029448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.
    Pimentel M; Morales W; Rezaie A; Marsh E; Lembo A; Mirocha J; Leffler DA; Marsh Z; Weitsman S; Chua KS; Barlow GM; Bortey E; Forbes W; Yu A; Chang C
    PLoS One; 2015; 10(5):e0126438. PubMed ID: 25970536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of gastro-esophageal reflux-type symptoms in individuals with irritable bowel syndrome in the community: a meta-analysis.
    Lovell RM; Ford AC
    Am J Gastroenterol; 2012 Dec; 107(12):1793-801; quiz 1802. PubMed ID: 23032982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence Against Routine Testing of Patients With Functional Gastrointestinal Disorders for Celiac Disease: A Population-based Study.
    Choung RS; Rubio-Tapia A; Lahr BD; Kyle RA; Camilleri MJ; Locke GR; Talley NJ; Murray JA
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1937-43. PubMed ID: 25987301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Severity of Symptoms Related to Irritable Bowel Syndrome is a Risk Factor for the Misclassification of Significant Organic Disease.
    Carter D; Beer-Gabel M; Derazne E; Tzur D; Bardan E
    J Clin Gastroenterol; 2017; 51(5):421-425. PubMed ID: 27348318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy.
    Wolf J; Petroff D; Richter T; Auth MKH; Uhlig HH; Laass MW; Lauenstein P; Krahl A; Händel N; de Laffolie J; Hauer AC; Kehler T; Flemming G; Schmidt F; Rodrigues A; Hasenclever D; Mothes T
    Gastroenterology; 2017 Aug; 153(2):410-419.e17. PubMed ID: 28461188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.